Who
Greg Keenan
SVP, Chief Medical Officer
Company insider
Files Form 4 as: SVP, Chief Medical Officer, Aurinia Pharmaceuticals.
In numbers
- Trades disclosed
- 13
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $376K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 28 Feb 2025
- Last trade
- 6 Mar 2026
- Last filed
- 10 Mar 2026
Companies traded
Activity over time
1 Mar 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Mar 2026filed 10 Mar 2026 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $116K8,069 at $14.32 | filing |
| 6 Mar 2026filed 10 Mar 2026 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $116K8,069 at $14.32 | filing |
| 27 Feb 2026filed 3 Mar 2026 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —40,586 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | AUPH Aurinia Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —67,870 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | AUPH Aurinia Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —67,870 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —40,586 at $0.00 | filing |
| 2 Feb 2026filed 3 Feb 2026 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $168K11,552 at $14.53 | filing |
| 2 Feb 2026filed 3 Feb 2026 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $168K11,552 at $14.53 | filing |
| 1 Aug 2025filed 5 Aug 2025 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $210K20,000 at $10.50 | filing |
| 7 Mar 2025filed 7 Mar 2025 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $68K8,305 at $8.23 | filing |
| 3 Mar 2025filed 4 Mar 2025 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $98K12,239 at $8.00 | filing |
| 28 Feb 2025filed 4 Mar 2025 | AUPH Aurinia Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —95,570 at $0.00 | filing |
| 28 Feb 2025filed 4 Mar 2025 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —62,583 at $0.00 | filing |
News
Aurinia Pharmaceuticals (NASDAQ:AUPH) Shares Cross Above Fifty Day Moving Average – Time to Sell?AUPH · tickerreport.com · 17 Oct 2026Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Price Crosses Above 50-Day Moving Average – Here's What HappenedAUPH · themarketsdaily.com · 9 Oct 2026
0 headlines in the last 90 days name Greg Keenan; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.